Skip to main content
Top
Published in: CEN Case Reports 4/2020

01-11-2020 | Candida Balanitis | Case Report

Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment

Authors: Takashi Iijima, Tatsuya Suwabe, Keita Inui, Hiroki Mizuno, Rikako Hiramatsu, Masayuki Yamanouchi, Naoki Sawa, Kenmei Takaichi, Yoshifumi Ubara

Published in: CEN Case Reports | Issue 4/2020

Login to get access

Abstract

We report a case of superinfection of liver cysts caused by Candida albicans and Staphylococcus lugdunensis in a patient with autosomal dominant polycystic kidney disease. A 69-year-old man with chief complaints of headache and blurred vision was admitted to the former institution for the evaluation of suspected temporal arteritis. He was prescribed oral prednisolone (55 mg/day) as a preemptive treatment; however, he became febrile and presented with bilateral flank pain during prednisolone tapering. Blood culture revealed fungemia as a result of Candida famata infection; thus, micafungin treatment was started. Thereafter, recrudescence of the C-reactive protein level ensued. Then a cyst infection as visualized on magnetic resonance imaging led to cyst aspiration sclerotherapy. Cyst aspirate culture revealed the presence of C. albicans in one of the cysts and S. lugdunensis in two of the cysts. The patient was clinically stabilized with an additional 3 weeks of antibiotic and antifungal drug administration.
Literature
1.
go back to reference Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4(7):1183–9.CrossRef Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4(7):1183–9.CrossRef
2.
go back to reference Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH. Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease. Neth J Med. 2018;76(5):226–34.PubMed Lantinga MA, de Sévaux RGL, Gevers TJG, Oyen WJG, de Fijter JW, Soonawala D, Zietse R, Salih M, Casteleijn NF, Spithoven EM, Meijer E, Gansevoort RT, Drenth On Behalf Of The Dipak Consortium JPH. Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease. Neth J Med. 2018;76(5):226–34.PubMed
3.
go back to reference Matthews S, Sloan S, McCaffrey D, Ruiz A. Septic Arthritis of the Hip Complicated by Secondary Fungal Superinfection. J Orthop Case Rep. 2017;7(1):46–9.PubMedPubMedCentral Matthews S, Sloan S, McCaffrey D, Ruiz A. Septic Arthritis of the Hip Complicated by Secondary Fungal Superinfection. J Orthop Case Rep. 2017;7(1):46–9.PubMedPubMedCentral
4.
go back to reference Renk H, Neunhoeffer F, Hölzl F, Hofbeck M, Kumpf M. Enterococcus faecium mediastinitis complicated by disseminated Candida parapsilosis infection after congenital heart surgery in a 4-week-old baby. Case Rep Infect Dis. 2015;2015:543685.PubMedPubMedCentral Renk H, Neunhoeffer F, Hölzl F, Hofbeck M, Kumpf M. Enterococcus faecium mediastinitis complicated by disseminated Candida parapsilosis infection after congenital heart surgery in a 4-week-old baby. Case Rep Infect Dis. 2015;2015:543685.PubMedPubMedCentral
5.
go back to reference Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013;68(2):438–43.CrossRef Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013;68(2):438–43.CrossRef
6.
go back to reference Zinkernagel AS, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, Zbinden R, Mueller NJ. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection. 2008;36(4):314–21.CrossRef Zinkernagel AS, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, Zbinden R, Mueller NJ. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection. 2008;36(4):314–21.CrossRef
7.
go back to reference Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol. 1991;29(3):419–21.CrossRef Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol. 1991;29(3):419–21.CrossRef
8.
go back to reference Nesher L, Tarrand J, Chemaly RF, Rolston KV. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer. 2017;25(4):1063–9.CrossRef Nesher L, Tarrand J, Chemaly RF, Rolston KV. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer. 2017;25(4):1063–9.CrossRef
9.
go back to reference Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.CrossRef Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.CrossRef
10.
go back to reference Telenti A, Torres VE, Gross JB Jr, Van Scoy RE, Brown ML, Hattery RR. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc. 1990;65(7):933–42.CrossRef Telenti A, Torres VE, Gross JB Jr, Van Scoy RE, Brown ML, Hattery RR. Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc. 1990;65(7):933–42.CrossRef
11.
go back to reference Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract. 2009;112(3):c157–c163163.CrossRef Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract. 2009;112(3):c157–c163163.CrossRef
12.
go back to reference Balbo BE, Sapienza MT, Ono CR, Jayanthi SK, Dettoni JB, Castro I, Onuchic LF. Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Braz J Med Biol Res. 2014;47(7):584–93.CrossRef Balbo BE, Sapienza MT, Ono CR, Jayanthi SK, Dettoni JB, Castro I, Onuchic LF. Cyst infection in hospital-admitted autosomal dominant polycystic kidney disease patients is predominantly multifocal and associated with kidney and liver volume. Braz J Med Biol Res. 2014;47(7):584–93.CrossRef
13.
go back to reference Nakanishi Y, Kayahara T, Yamashita Y, Okuno M, Nakamura F, Taniguchi Y, Inoue N, Nakatani Y, Hatamaru K, Shimizu T, Tanaka A, Yoshioka T, Seta T, Urai S, Uenoyama Y. A case of ruptured giant liver cyst complicated by Candida infection. Nihon Shokakibyo Gakkai Zasshi. 2009;106(7):1056–62.PubMed Nakanishi Y, Kayahara T, Yamashita Y, Okuno M, Nakamura F, Taniguchi Y, Inoue N, Nakatani Y, Hatamaru K, Shimizu T, Tanaka A, Yoshioka T, Seta T, Urai S, Uenoyama Y. A case of ruptured giant liver cyst complicated by Candida infection. Nihon Shokakibyo Gakkai Zasshi. 2009;106(7):1056–62.PubMed
14.
go back to reference Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med. 1988;108(1):88–100.CrossRef Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med. 1988;108(1):88–100.CrossRef
15.
go back to reference Guarner J. Human immunodeficiency virus and fungal infections. Semin Diagn Pathol. 2017;34(4):325–31.CrossRef Guarner J. Human immunodeficiency virus and fungal infections. Semin Diagn Pathol. 2017;34(4):325–31.CrossRef
Metadata
Title
Candida albicans and Staphylococcus lugdunensis superinfection of liver cysts in a patient with autosomal dominant polycystic kidney disease under prednisolone treatment
Authors
Takashi Iijima
Tatsuya Suwabe
Keita Inui
Hiroki Mizuno
Rikako Hiramatsu
Masayuki Yamanouchi
Naoki Sawa
Kenmei Takaichi
Yoshifumi Ubara
Publication date
01-11-2020

Other articles of this Issue 4/2020

CEN Case Reports 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.